Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
Clinical trial NCT06768697 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06768697
- Sponsor
- Shanghai Public Health Clinical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2025-12-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.